Reconnect and Rediscover: Four Seasons Invites Couples on an Urban Getaway Filled with Memorable Experiences to Enjoy Together

TORONTO, Sept. 20, 2021 /PRNewswire/ — Leading luxury hospitality brand Four Seasons Hotels and Resorts continues to welcome back travellers and local guests safely with a host of new experiences around the world, including the new ways to Reconnect and Rediscover through experiences…

Biotech Company, OneSkin, Makes Key Head of Operations Hire

SAN FRANCISCO, Sept. 20, 2021 /PRNewswire/ — Biotechnology company OneSkin, today announced the hire of a Head of Operations to join the female-led brand. An expert in organizational leadership, Robin Cagan will take on the role of leading processes and compliance for the brand, along…

Omnicom Agrees to Acquire antoni

NEW YORK, Sept. 20, 2021 /PRNewswire/ — Omnicom Group Inc. (NYSE: OMC) today announced it has agreed to acquire antoni, a Berlin-based, digitally-native advertising agency. antoni is one of the most innovative and creative advertising agencies in Europe. Since its launch in 2015 with its…

Omnicom Agrees to Acquire OSK

NEW YORK, Sept. 20, 2021 /PRNewswire/ — Omnicom Group Inc. (NYSE: OMC), today announced it has agreed to acquire Oliver Schrott Kommunikation GmbH (OSK), one of Germany’s leading public relations and communication agencies. OSK will operate as a stand-alone brand within Omnicom Public…

Tax Accounting Services Market will have an Incremental CAGR of 5.87% by 2025 | SpendEdge

NEW YORK, Sept. 19, 2021 /PRNewswire/ — SpendEdge has been monitoring the Tax Accounting Services Market and it is poised to grow by USD 5.58 Billion during 2021-2025. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the…

Novartis presents new Kisqali® data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer

EAST HANOVER, N.J., Sept. 19, 2021 /PRNewswire/ — Novartis today announced results of the final overall survival (OS) analysis of the Phase III MONALEESA-2 study, which evaluated Kisqali® (ribociclib) in combination with letrozole compared to placebo plus letrozole in postmenopausal…

Byondis ESMO Late-Breaking Presentation Confirms ADC [Vic-] Trastuzumab Duocarmazine (SYD985) Superior to Physician’s Choice in Pre-treated Locally Advanced or Metastatic HER2-Positive Breast Cancer

NIJMEGEN, Netherlands, Sept. 19, 2021 /PRNewswire/ — At a late-breaking oral presentation (LBA15) at the virtual 2021 ESMO Congress today, Byondis B.V., an independent, clinical stage biopharmaceutical company creating precision medicines, reported positive results from its pivotal Phase…

The Western China International Fair (WCIF) Holds in Chengdu on September 16-20, 2021

CHENGDU, China, Sept. 17, 2021 /PRNewswire/ — The opening ceremony of 18th Western China International Fair was held on September 16, 2021. At the ceremony, Hu Chunhua, member of the Political Bureau of the CPC Central Committee and Vice Premier of the State Council, declared the opening…

15TH Annual “Evening Before” Benefiting MPTF

CENTURY CITY, Calif., Sept. 19, 2021 /PRNewswire/ — Television’s biggest night took place in Century City, CA Saturday, September 18th, where the entertainment industry came together for the 15th annual “Evening Before” party, benefiting MPTF (Motion Picture & Television Fund). The…

2021 CSCO | Henlius will Release Four Oral Presentations of Two Upcoming Commercial Products: Novel anti-PD-1 mAb Serplulimab and Bevacizumab Biosimilar

SHANGHAI, Sept. 18, 2021 /PRNewswire/ — The 24th Annual Meeting of Chinese Society of Clinical Oncology (CSCO) will be held online and in-person from 25th to 29th September 2021. In this meeting, Henlius will release 4 study results of 2 products to be commercialized, the novel anti-PD-1…

« Previous PageNext Page »